Meta-Analysis Establishes Power of Local Therapies to Lower Breast Cancer Mortality

2005 ◽  
Vol 27 (4) ◽  
pp. 30
Author(s):  
Rabiya S. Tuma
Cancers ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 976
Author(s):  
Amanda Dibden ◽  
Judith Offman ◽  
Stephen W. Duffy ◽  
Rhian Gabe

In 2012, the Euroscreen project published a review of incidence-based mortality evaluations of breast cancer screening programmes. In this paper, we update this review to October 2019 and expand its scope from Europe to worldwide. We carried out a systematic review of incidence-based mortality studies of breast cancer screening programmes, and a meta-analysis of the estimated effects of both invitation to screening and attendance at screening, with adjustment for self-selection bias, on incidence-based mortality from breast cancer. We found 27 valid studies. The results of the meta-analysis showed a significant 22% reduction in breast cancer mortality with invitation to screening, with a relative risk of 0.78 (95% CI 0.75–0.82), and a significant 33% reduction with actual attendance at screening (RR 0.67, 95% CI 0.61–0.75). Breast cancer screening in the routine healthcare setting continues to confer a substantial reduction in mortality from breast cancer.


Trials ◽  
2013 ◽  
Vol 14 (1) ◽  
pp. 368 ◽  
Author(s):  
Sylvie Erpeldinger ◽  
Laure Fayolle ◽  
Rémy Boussageon ◽  
Marie Flori ◽  
Xavier Lainé ◽  
...  

2011 ◽  
Vol 20 (6) ◽  
pp. 845-852 ◽  
Author(s):  
Maria C. Magnus ◽  
Ma Ping ◽  
Miao Miao Shen ◽  
John Bourgeois ◽  
Jeanette H. Magnus

Sign in / Sign up

Export Citation Format

Share Document